Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Remifentanil Tapering and Post-adenotonsillectomy Pain in Children [Phase 4]
Phase 4 clinical trial examining remifentanil tapering and postoperative pain after adenotonsillectomy in children; the study is terminated.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Vibratory Anesthesia in Trigger Finger Injections [Phase 4]
A Phase 4 clinical trial update evaluating vibratory anesthesia for trigger finger injections, focusing on trigger finger pain and local ane…
-
CLINICAL_TRIALS withdrawal · 2023-08-18Clinical Trial Update: Pilot Trial: Comparing Buzzy to Intradermal Lidocaine for Peripheral IV Cannulation in Adults [Phase 4]
Pilot Phase 4 trial comparing Buzzy vs intradermal lidocaine for peripheral IV cannulation in adults was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: A Randomized Trial of NSAID Dosing Strategies [Phase 4]
A Phase 4 randomized trial evaluating dosing strategies for NSAIDs in musculoskeletal and acute pain conditions has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Comparison of Efficacy of Bupivacaine in Supraclavicular Block With or Without Dexmedetomidine [Phase 4]
Phase 4 trial comparing efficacy of bupivacaine in supraclavicular block with and without dexmedetomidine has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-10FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Nephron Pharmaceuticals Corporation)
FDA approved a supplemental application for Ketorolac Tromethamine from Nephron Pharmaceuticals Corporation, indicating approval of an updat…
-
FDA approval · 2023-08-08FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Ketorolac Tromethamine from Sun Pharmaceutical Industries, confirming continued marketing of the…
-
FDA approval · 2023-08-08FDA Approved: IBUPROFEN INFANTS — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's Ibuprofen Infants as an original application generic ibuprofen product intended for infants.
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain. [Phase 2]
A Phase 2 clinical trial of MR-107A-02 for post-surgical dental pain has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Empower Opioid Misuse & Chronic Pain [NA]
A completed clinical trial update related to opioid misuse and chronic pain is posted, but no detailed results are provided here.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427 [Phase 1]
Phase 1 single ascending dose study of ST-2427 evaluating safety, tolerability, and pharmacokinetics; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Exercise Dosing for Pain in Healthy Participants [NA]
Clinical trial assessing exercise dosing for pain in healthy participants has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating intravenous GSK3858279 effects on evoked pain tests in healthy volunteers; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Neuromodulatory Treatments for Pain Management in TBI [NA]
Clinical trial update on neuromodulatory treatments for pain management in traumatic brain injury, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Marijuana Use, Strength Training, and Alcohol Consumption (MUSTAC) Study [NA]
A completed clinical trial (MUSTAC) investigating marijuana use, strength training, and alcohol consumption in individuals with chronic pain…
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Managing Pain and Cognitions in Older Adults With Mild Cognitive Impairment or Memory Related Problems and Chronic Pain [NA]
A completed clinical trial investigating strategies to manage pain and cognition in older adults with mild cognitive impairment or memory-re…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment [Phase 4]
Phase 4 trial evaluating sublingual sufentanil in patients on Suboxone for acute pain; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Ketamine and Morphine Versus Morphine Alone for the Treatment of Acute Pain in the Emergency Department [NA]
A terminated clinical trial comparing ketamine plus morphine versus morphine alone for acute pain in the emergency department; results have …
-
FDA approval · 2023-07-10FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for Ketorolac tromethamine (generic) submitted by Onesource Specialty Pharma Limited under an ANDA (…
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Supplementary Epidural Analgesia in Video-Assisted Thoracic Surgery (VATS) - The SEAVATS Study [Phase 4]
Phase 4 clinical trial update evaluating supplementary epidural analgesia in video-assisted thoracic surgery for lung neoplasms.
-
FDA approval · 2023-06-26FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
The FDA approved a supplemental application for buprenorphine hydrochloride (generic buprenorphine HCl) submitted by PAI Holdings/PAI Pharma…
-
FDA approval · 2023-06-20FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Ketorolac tromethamine as an Original Application generic for Camber Pharmaceuticals, Inc., adding a new generic entry to the m…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Chronic Pain Risk Associated With Menstrual Period Pain [Phase 4]
Phase 4 clinical trial update examining chronic pain risk associated with menstrual period pain has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Hippocampal Stimulation in Chronic Low Back Pain [NA]
A completed clinical trial evaluating hippocampal stimulation for chronic low back pain; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer's Disease and Their Caregiver's [NA]
A completed clinical trial evaluating at-home telehealth yoga for chronic pain in people with Alzheimer disease and their caregivers; result…